• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS; ILIAC COVERED STENT, ARTERIAL Back to Search Results
Catalog Number BXA082902E
Device Problems Detachment of Device or Device Component (2907); Device Dislodged or Dislocated (2923); Physical Resistance/Sticking (4012)
Patient Problem Foreign Body In Patient (2687)
Event Date 11/03/2021
Event Type  malfunction  
Event Description
The patient presented with an abdominal aortic aneurysm that was treated with an endograft (cook medical) during a fenestrated endovascular aortic repair.A gore® viabahn® vbx balloon expandable endoprosthesis was used as a branch device to treat the left renal artery.Access was gained from the groin.They stated that they felt extreme high resistance when advancing the device (sn (b)(4)) through a 7fr aptus endosystems tourguide steerable sheath.Reportedly, high force was required to advance the device over the ostium into the renal artery.The physician stated that at this point xray imaging showed that the endoprosthesis dislodged and bunched on the balloon and eventually separated from the delivery catheter.They reported that they could not remove the endoprosthesis from the patient.The endoprosthesis remains in the aneurysmal sac.They then changed to another introducer sheath (medtronic) to advance another gore® viabahn® vbx balloon expandable endoprosthesis (sn (b)(4)) to the left renal artery.Reportedly, during advancement apparently the endoprosthesis loosened from the balloon but they managed to withdraw the endoprosthesis together with the delivery catheter from the patient.Another gore® viabahn® vbx balloon expandable endoprosthesis (sn (b)(4)) was used to complete the procedure successfully.Reportedly the patient is doing well.
 
Manufacturer Narrative
Patient height: 181 cm.The year of birth of the patient is (b)(6).(b)(6) was used as a best estimate for the date of birth.(b)(4).Cbas® heparin surface incorporates cbas-heparin manufactured from heparin sodium api, which is covalently bound to the device surface and is essentially non-eluting.
 
Manufacturer Narrative
H6-code 213: two screenshots of the case have been provided for evaluation.Several requests were emailed to the physician to provide the dicom imaging series of the case.The requests remained unanswered.An imaging evaluation was performed based on the event description and the provided screenshots.The imaging evaluation summary states the following: the images received cannot be used to perform a full imaging evaluation because they do not meet the dicom standard and the image quality is poor.The extent and accuracy of the observations and findings may be limited due to the completeness, format and/or quality of the images provided for review.Gore cannot guarantee the images provided are complete, accurate or lack alteration.Therefore, gore cannot guarantee all key findings have been captured or that the findings are accurate.- the images indicate the tourguide steerable sheath being used with ~90 degrees of angulation.- there is no evidence of a device being delivered, pre-deployment or deployment.- there appears to be a vbx stent deployed but unable to ascertain its location.- no guide wire appears to be within the left renal artery.Two devices are involved in this incident, therefore two reports have been submitted: manufacturer report number 2017233-2021-02587.
 
Manufacturer Narrative
H6: code 4117 and 213: the device dislodged and could not be retrieved from the patient.It remains in the aneurysmal sac.Therefore, a product evaluation could not be performed.The cause of the reported failure mode of covered stent displacement or removal from delivery system during insertion, could not be established with the information provided, including evaluation of the returned images.It was reported in the complaint description that the physician felt extreme high resistance when advancing the vbx device through the sheath.Reportedly, high force was required to advance the device over the ostium into the renal artery.There is a reasonably foreseeable misuse associated with stent migration (including endoprosthesis displacement or dislodgement), related to using too high of a force when advancing the delivery catheter.Contribution of this foreseeable misuse to the endoprosthesis being displaced on the delivery catheter during advancement could not be established, as it could not be confirmed whether the force applied was too high.
 
Manufacturer Narrative
Section h6: added further applicable codes.H6: codes 22 and 4315 and 61: conclusion: it was reported to gore that the physician felt extreme high resistance when advancing the vbx device through the introducer sheath.Reportedly, also high force was required to advance the vbx device over the ostium into the renal artery.There is a reasonably foreseeable misuse associated with stent migration (including endoprosthesis displacement or dislodgement), related to using high force when advancing the delivery catheter.The cause of reported stent displacement or dislodgement from the delivery catheter is consistent with a reasonably foreseeable misuse related to the application of force to further advancement after meeting resistance.The instructions for use of the gore® viabahn® vbx balloon expandable endoprosthesis recommends that if excessive resistance is felt, the delivery catheter and sheath be removed together as a unit: introduction and positioning of the gore® viabahn® vbx balloon expandable endoprosthesis: with the delivery catheter as straight as possible, insert the guidewire into the tip of the delivery catheter while supporting the delivery catheter and the endoprosthesis.Carefully advance the endoprosthesis in small increments (approximately 0.5 cm) over the guidewire, through the hemostasis valve and introducer sheath, and into the access vessel.Note: if excessive resistance is felt as the gore® viabahn® vbx balloon expandable endoprosthesis is introduced through the hemostasis valve, remove and inspect the delivery catheter for damage.Do not reuse the gore® viabahn® vbx balloon expandable endoprosthesis if damaged or if the covered stent is fluoroscopically observed to be displaced relative to the radiopaque markers on the delivery catheter.Ensure a compatible introducer sheath size (table 1) is used, and that the introducer sheath is free of kinks.Do not insert the shrink sleeve or the hub assembly into the introducer sheath.Using fluoroscopic guidance, advance the delivery catheter over the guidewire via the angiographic sheath.Advance cautiously, especially if resistance is felt.If excessive resistance is felt, remove the delivery catheter and sheath together as a unit.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS
Type of Device
ILIAC COVERED STENT, ARTERIAL
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
sibylle staerk
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key12922635
MDR Text Key281669637
Report Number2017233-2021-02588
Device Sequence Number1
Product Code PRL
Combination Product (y/n)Y
Reporter Country CodeAU
PMA/PMN Number
P160021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 06/02/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/03/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/21/2024
Device Catalogue NumberBXA082902E
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/25/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/22/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age75 YR
Patient SexMale
Patient Weight91 KG
-
-